These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 39223571)

  • 1. Self-report underestimates the frequency of the acute respiratory exacerbations of COPD but is associated with BAL neutrophilia and lymphocytosis: an observational study.
    Abrham Y; Zeng S; Lin W; Lo C; Beckert A; Evans L; Dunn M; Giang B; Thakkar K; Roman J; Blanc PD; Arjomandi M
    BMC Pulm Med; 2024 Sep; 24(1):433. PubMed ID: 39223571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Characteristics and Frequency of Chronic Obstructive Pulmonary Disease Exacerbations in Korean Patients: Findings From the KOCOSS Cohort 2012-2021.
    Rhee CK; Choi JY; Park YB; Yoo KH
    J Korean Med Sci; 2024 May; 39(19):e164. PubMed ID: 38769923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic obstructive pulmonary disease exacerbation episodes derived from electronic health record data validated using clinical trial data.
    Sperrin M; Webb DJ; Patel P; Davis KJ; Collier S; Pate A; Leather DA; Pimenta JM
    Pharmacoepidemiol Drug Saf; 2019 Oct; 28(10):1369-1376. PubMed ID: 31385428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.
    Lenferink A; Brusse-Keizer M; van der Valk PD; Frith PA; Zwerink M; Monninkhof EM; van der Palen J; Effing TW
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011682. PubMed ID: 28777450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comprehension and recognition of acute exacerbation among chronic obstructive pulmonary disease patients].
    Jiang M; Ma JF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Oct; 34(10):1030-4. PubMed ID: 24378002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-reported alcohol intake and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study.
    Wetherbee EE; Niewoehner DE; Sisson JH; Lindberg SM; Connett JE; Kunisaki KM
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1363-70. PubMed ID: 26229455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort.
    Martinez CH; Murray S; Barr RG; Bleecker E; Bowler RP; Christenson SA; Comellas AP; Cooper CB; Couper D; Criner GJ; Curtis JL; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Kleerup E; Krishnan JA; Lazarus SC; Leidy NK; O'Neal W; Martinez FJ; Paine R; Rennard SI; Tashkin DP; Woodruff PG; Han MK;
    Ann Am Thorac Soc; 2017 May; 14(5):636-642. PubMed ID: 28459622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Airway Eosinophilia on Bronchoalveolar Lavage and the Risk of Exacerbations in COPD.
    Ho CG; Milne S; Li X; Yang CX; Leitao Filho FS; Cheung CY; Yang JSW; Hernández Cordero AI; Yang CWT; Shaipanich T; van Eeden SF; Leung JM; Lam S; Sin DD
    Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
    Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
    Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Association of Depressive Symptoms With Rates of Acute Exacerbations in Patients With COPD: Results From a 3-year Longitudinal Follow-up of the ECLIPSE Cohort.
    Yohannes AM; Mülerová H; Lavoie K; Vestbo J; Rennard SI; Wouters E; Hanania NA
    J Am Med Dir Assoc; 2017 Nov; 18(11):955-959.e6. PubMed ID: 28733182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of airway inflammation using sputum, BAL, and endobronchial biopsies in current and ex-smokers with established COPD.
    Wen Y; Reid DW; Zhang D; Ward C; Wood-Baker R; Walters EH
    Int J Chron Obstruct Pulmon Dis; 2010 Oct; 5():327-34. PubMed ID: 21037956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry.
    McKleroy W; Shing T; Anderson WH; Arjomandi M; Awan HA; Barjaktarevic I; Barr RG; Bleecker ER; Boscardin J; Bowler RP; Buhr RG; Criner GJ; Comellas AP; Curtis JL; Dransfield M; Doerschuk CM; Dolezal BA; Drummond MB; Han MK; Hansel NN; Helton K; Hoffman EA; Kaner RJ; Kanner RE; Krishnan JA; Lazarus SC; Martinez FJ; Ohar J; Ortega VE; Paine R; Peters SP; Reinhardt JM; Rennard S; Smith BM; Tashkin DP; Couper D; Cooper CB; Woodruff PG
    JAMA; 2023 Aug; 330(5):442-453. PubMed ID: 37526720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The burden of illness in patients with moderate to severe chronic obstructive pulmonary disease in Canada.
    Maleki-Yazdi MR; Kelly SM; Lam SY; Marin M; Barbeau M; Walker V
    Can Respir J; 2012; 19(5):319-24. PubMed ID: 23061077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study.
    Brightling CE; Bleecker ER; Panettieri RA; Bafadhel M; She D; Ward CK; Xu X; Birrell C; van der Merwe R
    Lancet Respir Med; 2014 Nov; 2(11):891-901. PubMed ID: 25208464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Biomarker Potential of the Neutrophil-to-Lymphocyte Ratio in Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Vaishnav B; Pailla R; Wadivkar A; Ummaleti H; Doshi NI
    Cureus; 2024 Aug; 16(8):e66750. PubMed ID: 39268318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive oxygen species in peripheral blood and sputum neutrophils during bacterial and nonbacterial acute exacerbation of chronic obstructive pulmonary disease.
    Vaitkus M; Lavinskiene S; Barkauskiene D; Bieksiene K; Jeroch J; Sakalauskas R
    Inflammation; 2013 Dec; 36(6):1485-93. PubMed ID: 23872721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT.
    Francis NA; Gillespie D; White P; Bates J; Lowe R; Sewell B; Phillips R; Stanton H; Kirby N; Wootton M; Thomas-Jones E; Hood K; Llor C; Cals J; Melbye H; Naik G; Gal M; Fitzsimmons D; Alam MF; Riga E; Cochrane A; Butler CC
    Health Technol Assess; 2020 Mar; 24(15):1-108. PubMed ID: 32202490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Recording of Acute Exacerbations of COPD in UK Primary Care Electronic Healthcare Records.
    Rothnie KJ; Müllerová H; Hurst JR; Smeeth L; Davis K; Thomas SL; Quint JK
    PLoS One; 2016; 11(3):e0151357. PubMed ID: 26959820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exacerbation-related impairment of quality of life and work productivity in severe and very severe chronic obstructive pulmonary disease.
    Solem CT; Sun SX; Sudharshan L; Macahilig C; Katyal M; Gao X
    Int J Chron Obstruct Pulmon Dis; 2013; 8():641-52. PubMed ID: 24376348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of exacerbations in chronic obstructive pulmonary disease--results from the Bergen COPD cohort study.
    Husebø GR; Bakke PS; Aanerud M; Hardie JA; Ueland T; Grønseth R; Persson LJ; Aukrust P; Eagan TM
    PLoS One; 2014; 9(10):e109721. PubMed ID: 25279458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.